Glargine use was associated with a significantly decreased risk of colon cancer compared to non-glargine use breast cancer were marginally significant, while any cancer, pancreatic, liver, bladder, colorectal, respiratory and prostate cancer was not statistically significant.
← all excerpts
Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.
2
—
—
The sentences
Significant increased risk of cancer for the exposure contrast insulin versus no insulin was found for cancer in pancreas, liver, kidney and the respiratory system, and a marginal significance for stomach cancer.